Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

sed on current expectations and involve a number of known and unknown risks and uncertainties that could cause the final results to differ significantly from the results summarized by such statements. Some of the clinical trials described in this release are being conducted by independent investigators and Pharmion does not control and cannot predict the final results of those trials. Top line or preliminary results may not be confirmed upon full analysis of the detailed results of a trial and additional information relating to the safety, efficacy or tolerability of Vidaza may be discovered upon further analysis of clinical trial data and upon review and analysis of data from other clinical trials. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Pharmion also disclaims any duty to comment upon or correct information that may be contained in reports published by the investment community.

# # #

-------------------

(Back to top)

PHARMION AND METHYLGENE REPORT PRELIMINARY DATA FOR MGCD0103 AT THE 43rd AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

HDAC INHIBITOR MGCD0103 DEMONSTRATES substantial RESPONSE RATE IN TWO CLINICAL TRIALS

40% Response Rate and 45% Disease Control Rate in Single-Agent Phase II Trial in Refractory or Relapsed Hodgkin's Lymphoma Patients

30% Response Rate (37% at Relevant Active Doses) in Phase I/II Combination Trial with Vidaza(r) in MD
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:8/21/2014)... 21, 2014  Aptuit LLC announces that Aptuit ... , has enhanced its capabilities in the ... and large molecules, including biologic drugs, metabolites, and ... Q-TOF mass spectrometer. In making the ... said, "The expanded large molecule capability enhances our ...
(Date:8/21/2014)...   Memorial Hermann Health System and The ... a new partnership to provide a new level of specialized ... in the greater Houston area. ... exclusive provider of professional breast radiology services for five of ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a multivariate ... has appointed Holly B. Bauzon as Vice ... Bauzon has a proven track record in both increasing ... companies. She has more than 20 years of healthcare ... the position of Director, Lab Services Sales and Managed ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... dysfunction between the ages of 40 and 49 are twice ... according to a new Mayo Clinic study. Researchers also found ... risk of heart disease. "The highest risk for coronary heart ... Ph.D. The study was published in the February 2009 issue ...
... of ABthrax will bring at least $150 million ... Human Genome Sciences, Inc. (Nasdaq: ... delivery of 20,000 doses of its human monoclonal ... National Stockpile for use in the treatment of ...
Cached Medicine Technology:Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 2Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 3Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile 2Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile 3Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile 4Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile 5Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile 6Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile 7
(Date:8/21/2014)... August 21, 2014 Pack Expo ... Packaging and Processing Technologies. They deliver the industry’s ... into a whole new world of advancement and ... interactive education, and the latest technology and innovations ... exhibitors. This year at Pack Expo International, 50,000 ...
(Date:8/21/2014)... Living in a quality residential community means enjoying ... it. A quality Home Owners Association like the one ... , Simpson Mill Plantation, a ... Management, LLC made a recent investment in a quality ... additional amenity for their neighborhood. , Situated near a ...
(Date:8/21/2014)... a challenge. Thankfully, there are Zombies chasing you. , At ... 31,000 health and fitness apps on the market today, and ... to increase physical activity. , Gamification is currently the popular ... to help people get fit. Whether or not it,s the ... just been assumed that gamified apps will work, but there ...
(Date:8/21/2014)... source of fungal infections that have been sickening HIV/AIDS ... on trees. , The discovery is based on the ... summer gathering soil and tree samples from areas around ... named Cryptococcus gattii (CRIP-to-cock-us GAT-ee-eye). ... species including C. gattii , causes life-threatening infections ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Being born at ... for type 2 diabetes, a new study suggests. The ... a population that has a high prevalence of low birth ... 21,000 black women found that those with a low birth ... diabetes than those with a normal birth weight. The risk ...
Breaking Medicine News(10 mins):Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Playing hunger games: Are gamified health apps putting odds in your favor? 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2
... for Healthcare ProfessionalsVOORHEES, N.J., March 23 The ... is changing rapidly and has been marked by ... of CDI can be challenging and guidelines for ... to effectively implement key strategies for reducing the ...
... at East African Health Conference in Kenya SILVER ... Inc. (Danya), a communications, research, and technology firm, will ... effectiveness of mobile video-enabled phones in meeting the requirements ... the 3rd East African Health and Scientific Conference. ...
... March 23 Fujirebio Diagnostics, Inc., the premier ... cancer biomarker assays, today announced the appointment of ... Dr. Barnes comes to Fujirebio Diagnostics with 25 ... various positions at Abbott and Meridian Bioscience, most ...
... health insurances in Germany have offered an endoscopic examination ... insured persons from the age of 55. Germany was ... bowel cancer a part of its statutory early cancer ... Hermann Brenner at DKFZ have now published a first ...
... get relief from their symptoms and the psychological distress ... , Skin experts and psychologists at The University of ... known as ,electronic Targeted Intervention for Psoriasis, or eTIPS ... better. , "Psoriasis is a skin disease that usually ...
... Clinical Gold Standard Status for VTE Prophylaxis in ... ResourcesWALTHAM, Mass., March 23 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that surveyed ... prevention of venous thromboembolism (VTE) is the attribute ...
Cached Medicine News:Health News:Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 3Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 4Health News:Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer 2Health News:Germany: Colonoscopy prevents 15,000 cancer cases 2Health News:Experts turn to Web to combat distressing skin disease 2Health News:Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients 2
The Gold Standard Interference Screw is designed to provide solid fixation of bone patellar tendon grafts in ACL and PCL fixation. Its innovative thread design provides excellent fixation of bone bl...
... True/Flex Upper Extremity Intramedullary Rod System offers ... to conventional methods of rodding and plating. ... at the fracture site and enhanced healing4 ... to be easily inserted into the canal. ...
... Provides stable positioning of a patient during hip ... for stable positioning of a patient during total ... attach directly to the operating table utilizing the ... made of semi-dense foam to help prevent pressure ...
... Operating Table has exceptional versatility in ... positioning of fingers and thumb for ... hand, fingers and forearm. It ... base and single use supports and ...
Medicine Products: